Tim-3 pathway dysregulation and targeting in sepsis-induced immunosuppression by Jialiu Luo, Cong Zhang, Deng Chen, Teding Chang, Shunyao Chen, Zhiqiang Lin, Chengla Yi, Zhao-Hui Tang

Subjects: Get full text

Reduced T and NK Cell Activity in Glioblastoma Patients Correlates with TIM-3 and BAT3 Dysregulation by Farah Ahmady, Peter Curpen, Louis Perriman, Adilson Fonseca Teixeira, Siqi Wu, Hong-Jian Zhu, Arpita Poddar, Aparna Jayachandran, George Kannourakis, Rodney B. Luwor

Subjects: “…TIM-3…”
Get full text

TIM3 in COVID-19; A potential hallmark? by Mohammad Reza Zamani, Pavel Šácha

Subjects: Get full text

ALKBH5 acts a tumor-suppressive biomarker and is associated with immunotherapy response in hepatocellular carcinoma by Hehua Ma, Yuxin Hong, Zhenzhen Xu, Zuyi Weng, Yuanxun Yang, Dandan Jin, Zhiyou Chen, Xuan Zhou, Zhi Xu, Fei Fei, Wei Song, Juan Li

Subjects: Get full text

Plasma soluble TIM-3 is increased in normoglycemic South Asian women compared to Nordic women after gestational diabetes mellitus and associated with markers of metaflammation by Helene Grannes, Archana Sharma, Anita Suntharalingam, Annika E. Michelsen, Pål Aukrust, Thor Ueland, Kåre I. Birkeland, Ida Gregersen, Sindre Lee-Ødegård, Bente Halvorsen

Subjects: Get full text

The Functional Role and Prognostic Significance of TIM-3 Expression on NK Cells in the Diagnostic Bone Marrows in Acute Myeloid Leukemia by Kai Sun, Zong-Yan Shi, Dai-Hong Xie, Ya-Zhe Wang, Hao Jiang, Qian Jiang, Xiao-Jun Huang, Ya-Zhen Qin

Subjects: Get full text

TIM3 and CTLA4 immune checkpoint polymorphisms are associated with acute myeloid leukemia in Saudi Arabia by Mashael Alqahtani, Ali Aljuaimlani, Jameel Al-Tamimi, Suliman Alomar, Lamjed Mansour

Subjects: Get full text

Promising immunotherapy targets: TIM3, LAG3, and TIGIT joined the party by Chenyu Lu, Yuanyan Tan

Subjects: Get full text